Related references
Note: Only part of the references are listed.Real world experiences: Pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis
Nazia Chaudhuri et al.
RESPIRATORY MEDICINE (2014)
Photosafety assessments on pirfenidone: Photochemical, photobiological, and pharmacokinetic characterization
Yoshiki Seto et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2013)
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future
Katerina M. Antoniou et al.
EUROPEAN RESPIRATORY REVIEW (2013)
Idiopathic Pulmonary Fibrosis Lung Function Is a Clinically Meaningful Endpoint for Phase III Trials
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Adverse Events of Pirfenidone for the Treatment of Pulmonary Fibrosis: A Meta-Analysis of Randomized Controlled Trials
Chunguo Jiang et al.
PLOS ONE (2012)
Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
Vincent Cottin
EUROPEAN RESPIRATORY REVIEW (2012)
Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis
Joyce S. Lee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
The rising incidence of idiopathic pulmonary fibrosis in the UK
V. Navaratnam et al.
THORAX (2011)
Antifibrotic activities of pirfenidone in animal models
C. J. Schaefer et al.
EUROPEAN RESPIRATORY REVIEW (2011)
Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Pirfenidone: an anti-fibrotic therapy for progressive kidney disease
Monique E. Cho et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Epidemiology of interstitial lung diseases in Greece
A. Karakatsani et al.
RESPIRATORY MEDICINE (2009)
Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults
C. M. Rubino et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
Hisashi Oku et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Effects of three anti-TNF-α drugs:: Etanercept, infliximab and pirfenidone on release of TNF-α in medium and TNF-a associated with the cell in vitro
K. J. Grattendick et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Pirfenidone inhibits the expression of HSP47 in TGF-β1-stimulated human lung fibroblasts
Seiko Nakayama et al.
LIFE SCIENCES (2008)
Idiopathic pulmonary fibrosis
Eric B. Meltzer et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Acute exacerbations of idiopathic pulmonary fibrosis
Harold R. Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
J. Gribbin et al.
THORAX (2006)
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
HZ Liu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
A Azuma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community
V von Plessen et al.
RESPIRATORY MEDICINE (2003)
Pirfenidone suppresses tumor necrosis factor-α, enhances interleukin-10 and protects mice from endotoxic shock
H Oku et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland
U Hodgson et al.
THORAX (2002)
Share Paper
